Cosentyx Drug Market: Growth Trends, Demand, and Future Outlook

The Cosentyx Drug Market is gaining momentum as the demand for advanced biologic therapies continues to rise across the treatment of chronic inflammatory and autoimmune conditions. Cosentyx, based on the active ingredient secukinumab, is an interleukin-17A (IL-17A) inhibitor used for several immune-mediated diseases, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.
https://www.wiseguyreports.com..../reports/cosentyx-dr